Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Roman Fischbach in Blood Vessel Diagnostics
Introduction
Roman Fischbach, a notable inventor based in Muenster, Germany, has made significant strides in the field of medical diagnostics. With a singular patent to his name, his work focuses on advancing the understanding and treatment of vascular issues, particularly coronary heart disease.
Latest Patents
Fischbach holds a patent for a "Method and data processing device to support diagnosis and/or therapy of a pathological change of a blood vessel." This innovative method involves acquiring a pixel-based or voxel-based first image of the blood vessel in question using advanced imaging techniques. By assessing the quantities of non-calcified and calcium-rich plaques present, the method yields an indicator value indicative of plaque quantity and composition. This value is then compared to pre-established limit values to yield recommendations for patient treatment or the absence thereof, streamlining the decision-making process in vascular therapy.
Career Highlights
Currently, Roman Fischbach is associated with Siemens Aktiengesellschaft, a leading global company known for its innovations in various technological fields. His expertise in medical imaging and data processing has positioned him as a vital contributor within the company, influencing advancements in patient care technologies.
Collaborations
Throughout his career, Fischbach has worked alongside talented colleagues, including Christoph Becker and Thomas Flohr. Their collaborations have fostered a dynamic environment for innovation, helping enhance the methodologies employed in vascular diagnostics and treatment.
Conclusion
Roman Fischbach's contributions to the field of medical diagnostics illustrate the profound impact that innovative thinking can have on healthcare. His patent represents a critical advancement in the diagnosis and therapy of vascular conditions, and his ongoing work at Siemens Aktiengesellschaft suggests that he will continue to play a pivotal role in transforming patient care methodologies.